Initial Excisional Biopsy Is Associated With Reduced Breast-Conserving Surgery Compared With Core Needle Biopsy in BI-RADS 4–5 Breast Lesions
This study demonstrates that for high-risk BI-RADS 4–5 breast lesions, initial excisional biopsy without prior core needle biopsy leads to significantly higher mastectomy rates, increased residual tumor findings, and compromised surgical planning compared to core needle biopsy, supporting the latter as the essential primary diagnostic modality.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine your breast is a bustling city, and a suspicious lump is like a mysterious, uninvited guest knocking at the door. The big question for the doctors is: How do we figure out who this guest is without causing a city-wide panic or ruining the neighborhood?
This study, conducted by a team of researchers in Turkey, looks at two very different ways of handling this "knock at the door." They compared two groups of patients with high-risk lumps (labeled BI-RADS 4–5, which means the city planners were pretty sure something was wrong).
The Two Approaches: The "Smash-and-Grab" vs. The "Spy Mission"
The first group of patients (28 people) went through what the researchers call an excisional biopsy. Think of this as the "Smash-and-Grab" method. Instead of sending in a tiny spy to peek inside, the surgeons went straight in and cut the whole lump out immediately, often at a smaller hospital without fancy imaging tools. They hoped to get a diagnosis this way.
The second group (50 people) went through a Core Needle Biopsy (CNB). This is the "Spy Mission." Using a hollow needle guided by ultrasound or X-ray, doctors took a tiny sample of the tissue—like a spy grabbing a single piece of evidence—without cutting the whole thing out. This is the modern, standard way to do things.
The Big Discovery: Why the "Smash-and-Grab" Backfires
The study found that the "Smash-and-Grab" approach caused a massive chain reaction of problems. Here is what happened:
The "All or Nothing" Surgery: Because the first surgery (the excisional biopsy) was just a guess-and-check, the surgeons often messed up the map of the city. When the patient arrived at the main hospital, the doctors realized they couldn't tell where the "bad" tissue ended and the "good" tissue began.
- In the Spy Mission group, half of the patients (50.0%) got to keep their breast with a Breast-Conserving Surgery (BCS). They got to save their home!
- In the Smash-and-Grab group, only 21.4% got to keep their breast. The other 75.0% had to have a Mastectomy (removal of the whole breast) or a Modified Radical Mastectomy. The researchers say this is because the first cut ruined the chance to save the rest.
The "Ghost" Problem: In 21.4% of the Smash-and-Grab patients, when they finally did the big surgery, the doctors found no tumor left in the tissue they removed. It turns out the first surgery had already taken the whole thing out, but because they didn't know it was cancer before they cut, they had to go back in and do a second, unnecessary surgery just to be sure. It's like tearing down a whole house because you thought you saw a rat, only to find out the rat was already gone, but you still had to rebuild the porch.
The Broken Compass (Lymph Nodes): The body has a drainage system called lymph nodes, which act like a compass to tell doctors if the cancer has spread. The first surgery in the Smash-and-Grab group messed up the drainage pipes.
- In the Spy Mission group, the compass failed 16% of the time (meaning it worked 84% of the time).
- In the Smash-and-Grab group, the compass failed 25% of the time.
- Because the compass was broken, doctors often had to remove more lymph nodes (Axillary Lymph Node Dissection) just to be safe, which causes more swelling and pain later on.
The Double Trouble: Every single patient in the Smash-and-Grab group had to go back to the operating room for a second surgery. Some had to wait 34.4 days on average just to get the final treatment started. The Spy Mission group didn't have this delay.
The Verdict: Don't Smash the Door
The researchers ran the numbers and found that if you start with a "Smash-and-Grab" biopsy, you are nearly 3 times more likely (specifically, an Odds Ratio of 2.84) to end up losing your breast compared to starting with a "Spy Mission" (Core Needle Biopsy).
The paper is very clear: Excisional biopsy should not be the first step. It argues that doing a big cut before you know what you are dealing with is like trying to solve a puzzle by throwing away half the pieces. It leads to more mastectomies, more failed lymph node checks, more complications (66.7% of breast-saving patients in the bad group had complications vs. 24% in the good group), and a lot more stress.
The study suggests that the only time you should ever do a "Smash-and-Grab" is if the "Spy Mission" (the needle biopsy) gives a confusing answer that doesn't match what the X-rays show. Otherwise, the needle is the hero, and the big knife should stay in the box until the diagnosis is confirmed.
How Sure Are They?
The authors are quite confident in these findings based on the data they collected from 78 patients between 2023 and 2025. They used strict math to show that the difference in mastectomy rates (75% vs. 50%) wasn't just luck; it was a real pattern. However, they admit their study was done at just one hospital and looked back at old records, so they can't promise this is the only truth for every single person in the world. But the evidence they have strongly suggests that sticking to the needle biopsy saves breasts and saves patients from unnecessary second surgeries.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.